Skip to content

Trial to Compare Intracorporeal with Extracorporeal Ileal Conduit After Laparoscopic Radical Cystectomy

Trial to Compare Intracorporeal with Extracorporeal Ileal Conduit After Laparoscopic Radical Cystectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011747
Enrollment
Unknown
Registered
2017-06-29
Start date
2017-07-10
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Interventions

Control:Laparoscopic Radical Cystectomy with Extracorporeal ileal Conduit
Experimental:Laparoscopic Radical Cystectomy with Intracorporeal ileal Conduit

Sponsors

Beijing Chao-yang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years; 2. Muscle-invasive bladder cancer (T2-T4a, N0-x, M0); Multiple recurrent non-muscle invasive bladder cancer; G3 non-muscle invasive bladder cancer; multiple carcinoma in situ; extensive papillary disease can not be controlled by conservasive treatment; recurrent or unresponse after bladder-preserving treatment; Non-transitional cell carcinoma in bladder; 3. Zubrod-ECOG-WHO (ZPS) Grade:0-2; 4. Patients provided voluntary informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patient with distant metastasis disease; 2. Co-exist intestinal disease; 3. Previous resection of small intestine; 4. Severe heart insufficiency, decompensated pulmonary, liver, renal functons, or other severe systemic disease; 5. Other situation which was recognized should be excluded by the researcher.

Design outcomes

Primary

MeasureTime frame
Postoperative Complication;

Secondary

MeasureTime frame
Operative Time;Estimated Blood Loss;Time to liquid diet;Tumor Recurrence;Tumor Metastasis;

Contacts

Public ContactNianzeng Xing

Beijing Chao-yang Hospital, Capital Medical University

xingnianzeng@hotmail.com+86 18601238866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026